CLINICAL_TRIALS ClinicalTrials.gov record update

Evaluating the Consistency of 3 Consecutive Lots of GSK Biologicals' Novel Adjuvanted HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as a Control, Administered According to a 0, 1, 2-month Schedule in Healthy Volunteers (15-50y).

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00697866
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:25.898219+00:00
Published At: 2016-09-16T00:00:00+00:00
Record Updated At: 2016-09-16
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Hepatitis B"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-09-16"
protocolSection.identificationModule.nctId: "NCT00697866"
protocolSection.identificationModule.officialTitle: "Evaluating the Consistency of 3 Consecutive Lots of GSK Biologicals\u0027 Novel Adjuvanted HBV Vaccine With Single-blind Safety Evaluation Using Engerix\u2122-B as a Control, Administered According to a 0, 1, 2-month Schedule in Healthy Volunteers (15-50y)."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.